Paper · 41459545
References156
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 156
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39280800 | The structural insights of L-asparaginase from Pseudomonas aeruginosa CSPS4 at elevated temperatures highlight its thermophilic nature. | 3 Biotech | 2024 | https://conductscience.org/library/papers/39280800 | PubMed |
| 2 | 39096839 | An ultra-long-acting L-asparaginase synergizes with an immune checkpoint inhibitor in starvation-immunotherapy of metastatic solid tumors. | Biomaterials | 2025 | https://conductscience.org/library/papers/39096839 | PubMed |
| 3 | 36182969 | Asparagine bioavailability regulates the translation of MYC oncogene. | Oncogene | 2022 | https://conductscience.org/library/papers/36182969 | PubMed |
| 4 | 28346428 | Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells. | Oncogene | 2017 | https://conductscience.org/library/papers/28346428 | PubMed |
| 5 | 36781296 | Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management. | Leuk Lymphoma | 2023 | https://conductscience.org/library/papers/36781296 | PubMed |
| 6 | 37060469 | L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. | Med Oncol | 2023 | https://conductscience.org/library/papers/37060469 | PubMed |
| 7 | 35669980 | Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy. | Blood Lymphat Cancer | 2022 | https://conductscience.org/library/papers/35669980 | PubMed |
| 8 | 39212097 | Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway. | IUBMB Life | 2024 | https://conductscience.org/library/papers/39212097 | PubMed |
| 9 | 34948436 | Highly Active Thermophilic L-Asparaginase from Melioribacter roseus Represents a Novel Large Group of Type II Bacterial L-Asparaginases from Chlorobi-Ignavibacteriae-Bacteroidetes Clade. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948436 | PubMed |
| 10 | 38535455 | Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies. | Mar Drugs | 2024 | https://conductscience.org/library/papers/38535455 | PubMed |
| 11 | 32256483 | Streptomyces spp. From the Marine Sponge Antho dichotoma: Analyses of Secondary Metabolite Biosynthesis Gene Clusters and Some of Their Products. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32256483 | PubMed |
| 12 | 27770857 | Marine Microorganism: An Underexplored Source of l-Asparaginase. | Adv Food Nutr Res | 2016 | https://conductscience.org/library/papers/27770857 | PubMed |
| 13 | 35682622 | Structural Aspects of E. coli Type II Asparaginase in Complex with Its Secondary Product L-Glutamate. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682622 | PubMed |
| 14 | 33599151 | Regulation and metabolic functions of mTORC1 and mTORC2. | Physiol Rev | 2021 | https://conductscience.org/library/papers/33599151 | PubMed |
| 15 | 35739087 | Asparagine synthetase regulates lung-cancer metastasis by stabilizing the β-catenin complex and modulating mitochondrial response. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35739087 | PubMed |
| 16 | 26694875 | Therapeutic l-asparaginase: upstream, downstream and beyond. | Crit Rev Biotechnol | 2017 | https://conductscience.org/library/papers/26694875 | PubMed |
| 17 | 31552479 | What makes a good new therapeutic L-asparaginase? | World J Microbiol Biotechnol | 2019 | https://conductscience.org/library/papers/31552479 | PubMed |
| 18 | 33907490 | Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review. | Blood Lymphat Cancer | 2021 | https://conductscience.org/library/papers/33907490 | PubMed |
| 19 | 39796613 | Targeting Asparagine Metabolism in Solid Tumors. | Nutrients | 2025 | https://conductscience.org/library/papers/39796613 | PubMed |
| 20 | 40316107 | Evaluating the potential of Halomonas pacifica DJ6.1 L-asparaginase: statistical production optimization, biochemical characterization and anticancer attributes using Caco-2 cell lines. | Int J Biol Macromol | 2025 | https://conductscience.org/library/papers/40316107 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/41459545/references